Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
Yusuke Kitagawa(Japanese Foundation For Cancer Research), Hiroshi Kawachi(Japanese Foundation For Cancer Research), Takashi Akiyoshi(The Japanese Society of Gastroenterological Surgery), Toshiki Mukai(Japanese Foundation For Cancer Research), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Yosuke Fukunaga(Japanese Foundation For Cancer Research), Toshiya Nagasaki(Japanese Foundation For Cancer Research), Noriko Yamamoto(Japanese Foundation For Cancer Research), Toru Hirota(The Cancer Institute Hospital), Tetsuo Noda(Japanese Foundation For Cancer Research), Yukiharu Hiyoshi(Japanese Foundation For Cancer Research)
Cited by 16
Related Papers
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
|Cancer Science|2014|238
The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II
|Genes & Development|2011|148
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
|European Journal of Surgical Oncology|2016|138
Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method
|Surgical Endoscopy|2014|132
Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer
|Annals of Surgery|2017|121